<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01784367</url>
  </required_header>
  <id_info>
    <org_study_id>PV4190</org_study_id>
    <nct_id>NCT01784367</nct_id>
  </id_info>
  <brief_title>Extracorporeal Lung Assist to Avoid Intubation in Patients Failing NIV for Hypercapnic ARF</brief_title>
  <acronym>ECLAIR</acronym>
  <official_title>Extracorporeal Lung Assist to Avoid Intubation in Patients Failing Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study´s intention is to evaluate the feasibility, safety and effectiveness of a pump
      driven extracorporeal device for removal of carbon dioxide from the blood in oder to avoid
      intubation and invasive mechanical ventilation in patients with acute respiratory failure
      retaining carbon dioxide due to the failure of their ventilatory muscle pump and not
      responding to prior non-invasive mask ventilation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study´s intention is to evaluate the feasibility, safety and effectiveness of a pump
      driven extracorporeal device for removal of carbon dioxide from the blood in oder to avoid
      intubation and invasive mechanical ventilation in patients with acute respiratory failure
      retaining carbon dioxide due to the failure of their ventilatory muscle pump and not
      responding to prior non-invasive mask ventilation. Since intubation with subsequent
      (prolonged) invasive mechanical ventilation is associated with considerable side effects this
      new strategy has the potential to improve overall clinical outcome in this selected patient
      group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of intubation for invasive mechanical ventilation</measure>
    <time_frame>21 days</time_frame>
    <description>Rate of intubation for invasive mechanical ventilation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of non-invasive ventilation</measure>
    <time_frame>21 days</time_frame>
    <description>Length of non-invasive ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rates</measure>
    <time_frame>3 months</time_frame>
    <description>Any complication associated with the pump driven extracorporeal lung assist device or with non-invasive or invasive mechanical ventilation or any associated treatments during the observational period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of invasive mechanical ventilation if intubated</measure>
    <time_frame>3 months</time_frame>
    <description>Length of invasive mechanical ventilation if intubated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in ICU and hospital</measure>
    <time_frame>3 months</time_frame>
    <description>Length of stay in ICU and hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>3 months</time_frame>
    <description>3-months-mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in blood gases and respiratory rate pre/post start of ECLA</measure>
    <time_frame>21 days</time_frame>
    <description>Changes in arterial blood gases before and after the initiation of the pump driven extracorporeal lung assist</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Hypercapnia</condition>
  <condition>Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>ECLA-group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with a pump driven, venovenous extracorporeal lung assist</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>vv-ECCO2R (Novalung GmbH, Germany)</intervention_name>
    <description>Treatment with the extracorporeal lung assist (ECLA) The ECLA is a pump driven (centrifugal pump) venovenous circuit, which removes carbon dioxide from the patients blood by means of a membrane through which the patients blood runs on the one side of the membrane and sweep gas on the other side removing the patient´s carbon dioxide. Blood flow range from 0.5 to 4.5 l/min and sweep gas flow between 1 and 10 l/min. At blood flows of 2 l/min and higher the device also oxygenates the patients blood. The diameter and length of cannulas and the sites of venous insertions are left to the decision of the treating physician. Cannulas are inserted in seldinger technique under sterile conditions. Function and patency of the extracorporeal circuit requires mild therapeutic anticoagulation.</description>
    <arm_group_label>ECLA-group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute or acute-on-chronic hypercapnic respiratory insufficiency (pH ≤ 7,35, PaCO2 &gt; 45
             mmHg)

          -  failure of noninvasive ventilation

          -  fulfilling criteria for endotracheal intubation

        Exclusion Criteria:

          -  under 18 years of age

          -  prior inclusion in other interventional study

          -  pregnancy

          -  heparin allergy or heparin-induced thrombocytopenia type 2

          -  on home non-invasive ventilator

          -  &quot;Do not resuscitate&quot; order or moribund condition

          -  life expectancy less than 6 months

          -  no informed consent available
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Kluge, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Intensive Care Medicine, University Medical-Center Hamburg-Eppendorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Intensive Care Medicine, University Medical-Center Hamburg-Eppendorf (plus 10 further centres in Germany, Austria and the Netherlands)</name>
      <address>
        <city>Hamburg</city>
        <zip>22399</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uke.de</url>
    <description>Department of principal investigator</description>
  </link>
  <reference>
    <citation>Kluge S, Braune SA, Engel M, Nierhaus A, Frings D, Ebelt H, Uhrig A, Metschke M, Wegscheider K, Suttorp N, Rousseau S. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation. Intensive Care Med. 2012 Oct;38(10):1632-9. Epub 2012 Jul 27.</citation>
    <PMID>22836139</PMID>
  </reference>
  <results_reference>
    <citation>Braune S, Sieweke A, Brettner F, Staudinger T, Joannidis M, Verbrugge S, Frings D, Nierhaus A, Wegscheider K, Kluge S. The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study. Intensive Care Med. 2016 Sep;42(9):1437-44. doi: 10.1007/s00134-016-4452-y. Epub 2016 Jul 25.</citation>
    <PMID>27456703</PMID>
  </results_reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2013</study_first_submitted>
  <study_first_submitted_qc>February 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2013</study_first_posted>
  <last_update_submitted>June 16, 2017</last_update_submitted>
  <last_update_submitted_qc>June 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Stefan Kluge</investigator_full_name>
    <investigator_title>PD Dr. Stefan Kluge</investigator_title>
  </responsible_party>
  <keyword>Hypercapnia</keyword>
  <keyword>noninvasive ventilation</keyword>
  <keyword>acute respiratory failure</keyword>
  <keyword>endotracheal intubation</keyword>
  <keyword>invasive mechanical ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

